tradmap

TWST Twist Bioscience Corp

$87.50 +5.54%

Healthcare · Biological Products, (No Diagnostic Substances)

Twist Bioscience Corp (TWST) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry, with a market capitalization of $5.4 billion. Shares last traded at $87.50, near their 52-week high. Over the past year the stock is up 157.9%. Net profit margin is -20.6%, below the peer median of 6.3%. Revenue grew 20.3% year over year.

Market Cap
$5.4B
Shares Out
62.3M
EPS (TTM)
$-3.75
P/E Ratio
P/S Ratio
14.47
P/B Ratio
11.97
Dividend / Share
Dividend Yield
52-Week High
$88.48
52-Week Low
$23.42
Volume
130,246
Avg Vol (3m)
77,217.095

Performance

1W
+18.06%
1M
+76.65%
3M
+95.08%
6M
+181.11%
YTD
+170.09%
1Y
+157.87%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
74.40
SMA (50)
$62.46
SMA (200)
$43.20
Price vs SMA50
+40.09%
Price vs SMA200
+102.53%
ATR (14)
$4.98

Financials

Revenue
$377M
Net Income
$-78M
Gross Margin
Operating Margin
-36.2%
Net Margin
-20.6%
Return on Equity
-17.1%
Return on Assets
-11.5%
Current Ratio
2.70
Debt / Equity
0.00
Revenue Growth (YoY)
+20.3%

Latest reported annual period ending 2025-09-30 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-1.21 2026-05-04
Q1 2026 $-0.50 2026-02-02
FY 2025 $-1.30 2025-11-17
Q3 2025 $-0.85 2025-08-04
Q2 2026 $-1.19 2026-05-04
Q1 2026 $-0.53 2026-02-02

Full earnings history →

Biological Products, (No Diagnostic Substances) peers

TWST vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap.

P/S vs peers
14.47 / 5.21 med
+178% premium
Net margin vs peers
-20.6% / 6.3% med
below median
1–14 of 14
AMGNAmgen$182.1B23.624.9621.0%-1.27%
GILDGilead Sciences$153.5B18.045.2128.9%-1.46%
RVMDRevolution Medicines, Inc.$34.6B-30.62+3.14%
BIIBBiogen$29.0B22.442.9313.1%-1.15%
MRNAModerna$25.4B-8.99+3.22%
NBIXNeurocrine Biosciences Inc$15.9B33.245.5616.7%-0.48%
EXELExelixis, Inc.$13.1B16.685.6233.7%-1.04%
KRYSKrystal Biotech, Inc.$10.2B50.0226.3352.6%+1.68%
TECHBio-Techne$9.1B123.617.446.0%+5.36%
HALOHalozyme Therapeutics, Inc.$8.1B25.675.8222.7%-0.03%
IBRXImmunitybio, Inc.$7.7B-21.87+5.01%
RGENRepligen Corp$7.4B152.2710.086.6%-1.20%
KYMRKymera Therapeutics, Inc.$7.4B23.88+0.44%
PCVXVaxcyte, Inc.$7.4B-9688.00+1.57%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.